Phase III Randomized Study of Adjuvant Immunotherapy With Monoclonal Antibody 17-1A Versus No Adjuvant Therapy Following Resection for State II (Modified Astler-Coller B2) Adenocarcinoma of the Colon
Phase of Trial: Phase III
Latest Information Update: 08 Sep 2016
At a glance
- Drugs Edrecolomab (Primary)
- Indications Colon cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 18 Jul 2016 Results (n=393) of a gene expression signature assay published in the Journal of Clinical Oncology.
- 16 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.